Who
Cyrus Taraporevala
Director
Company insider
Files Form 4 as: Director, Pfizer; EVP; President and CEO of SSGA, State Street.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Nov 2017
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,307.987 at $28.67 | filing |
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,307.99 at $28.67 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,543.845 at $24.29 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,543.85 at $24.29 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,386.834 at $27.04 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,386.83 at $27.04 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,506.024 at $24.90 | filing |
| 31 Dec 2025filed 5 Jan 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,506.02 at $24.90 | filing |
| 30 Sep 2025filed 2 Oct 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,471.74 at $25.48 | filing |
| 30 Jun 2025filed 2 Jul 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $38K1,547.03 at $24.24 | filing |
| 24 Apr 2025filed 28 Apr 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K8,999 at $22.78 | filing |
| 31 Mar 2025filed 2 Apr 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,479.87 at $25.34 | filing |
| 31 Dec 2024filed 3 Jan 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,413.49 at $26.53 | filing |
| 30 Sep 2024filed 2 Oct 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $37K1,295.78 at $28.94 | filing |
| 28 Jun 2024filed 1 Jul 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,64858.91 at $27.98 | filing |
| 27 Jun 2024filed 1 Jul 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $170K6,101.31 at $27.80 | filing |
| 25 Feb 2022filed 1 Mar 2022 | STT State StreetCapital Markets & Asset Management | SEC FORM 4 Code A | —21,604 at $0.00 | filing |
| 25 Feb 2022filed 1 Mar 2022 | STT State StreetCapital Markets & Asset Management | SEC FORM 4 Code A | —16,874 at $0.00 | filing |
News
State Street SPDR S&P Bank ETF Gains 0.78%, Remains Below Sept. 4 CloseSTT · econotimes.com · 20 Oct 2026Family Shares Update on 3-Year-Old Hit by Car on Santa Barbara's State StreetSTT · independent.com · 20 Oct 2026Colleen Macey: Why are Backers of the State Street Master Plan Afraid of Letting People Vote on It?STT · noozhawk.com · 19 Oct 2026
0 headlines in the last 90 days name Cyrus Taraporevala; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.